Stocks

FMCG : Volume Woes

Byaea2ede5_admin June 9, 2025

Source link

Stocks

Burning Grid Monthly Report – 08/2025
Byaea2ede5_admin September 2, 2025

🔥 Burning Grid – Monthly Report August 2025 August is usually a quiet month in the markets, but Burning Grid delivered another round of solid, controlled profits across all risk levels – despite lower trade volume due to seasonal factors. ☀️ Seasonal Context – Fewer Trades, Still Strong Performance August is shaped by lower volatility…

Read More Burning Grid Monthly Report – 08/2025
Stocks

Phase Two: Build Your First Trading System (PSTOC)
Byaea2ede5_admin December 28, 2025

SECTION 4 — Basics of Price Action & Market Behavior Goal: To teach you the fundamental building blocks of how price truly moves. By the end of this section, you will understand trends, ranges, pullbacks, breakouts, and reversals — and you will be able to read charts even without indicators. This section gives you the…

Read More Phase Two: Build Your First Trading System (PSTOC)
Stocks

Marathon Petroleum (NYSE:MPC) Given New $182.00 Price Target at Citigroup
Byaea2ede5_admin January 14, 2026

Citigroup lowered their target price on Marathon Petroleum from $185.00 to $182.00 and set a “neutral” rating on the stock in a report on Wednesday. Source link

Read More Marathon Petroleum (NYSE:MPC) Given New $182.00 Price Target at Citigroup
Stocks

Monday’s Movers, A Duo of New Ideas
Byaea2ede5_admin October 1, 2024

Another Week Off to a Strong Start: Things kicked off as well as could be hoped yesterday, despite not having any earnings reporters that really interested us. We hashed out a couple of possible ideas for our daily premarket report and got pretty good results back in both cases. We were looking at the PDD Weekly $140-142…

Read More Monday’s Movers, A Duo of New Ideas
Stocks

The Next Big Step in Genomics: Why CRISPR Therapeutics (CRSP) Could Deliver
Byaea2ede5_admin January 20, 2025

The field of gene editing has seen remarkable advancements over the past decade, with CRISPR-Cas9 technology leading the way. CRISPR Therapeutics (CRSP), one of the foremost players in this space, has made significant strides in applying this groundbreaking technology to develop gene-based treatments for serious diseases. The company’s lead therapy, CASGEVY (exagamglogene autotemcel or exa-cel),…

Read More The Next Big Step in Genomics: Why CRISPR Therapeutics (CRSP) Could Deliver
Stocks

Nvidia’s 2025 Won’t Be So Easy (NASDAQ:NVDA)
Byaea2ede5_admin December 31, 2024

Nvidia's 2025 Won't Be So Easy (Downgrade) Source link

Read More Nvidia’s 2025 Won’t Be So Easy (NASDAQ:NVDA)

Similar Posts

Leave a Reply Cancel reply